Article Details

CCI approves merger by absorption of Covidshield Technologies into Biocon Biologics in ...

Retrieved on: 2022-05-19 13:44:19

Tags for this article:

Click the tags to see associated articles and topics

CCI approves merger by absorption of Covidshield Technologies into Biocon Biologics in .... View article details on hiswai:

Excerpt

It has manufacturing facilities in Bengaluru and Malaysia for monoclonal antibodies, recombinant proteins and insulins.

Article found on: orissadiary.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up